Top News
Aurigene and Debiopharm Group™ report nomination of development candidate Debio 0617B in oncology
SBA Member News, 19.06.2013Aurigene Discovery Technologies, a Bangalore-based biotech focusing on small molecule and peptide drug discovery and Debiopharm Group™ (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, today announced the successful nomination of a development candidate, Debio 0617B.
moreAnergis Files Provisional U.S. Patent on AllerDM Dust Mite Allergy Treatment
SBA Member News, 19.06.2013more
Next Event
